Medigen Vaccine Biologics Corporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 2.949 million. Operating loss was TWD 204.459 million compared to TWD 121.897 million a year ago. Net loss was TWD 183.023 million compared to TWD 126.183 million a year ago. Basic loss per share was TWD 0.98 compared to TWD 0.81 a year ago. For the nine months, sales was TWD 4.580 million compared to TWD 640,000 a year ago. Operating loss was TWD 504.314 million compared to TWD 417.406 million a year ago. Net loss was TWD 487.292 million compared to TWD 427.151 million a year ago. Basic loss per share was TWD 2.66 compared to TWD 2.74 a year ago.